Brief: Everest Medicines Says Voluntary Lock-Up Undertaking By Controlling Shareholder
18/03/2024 01:32
March 18 (Reuters) - Everest Medicines Ltd 1952.HK :
* VOLUNTARY LOCK-UP UNDERTAKING BY CONTROLLING SHAREHOLDER
AND
CERTAIN SENIOR MANAGEMENT
* CONTROLLING SHAREHOLDERS VOLUNTARILY UNDERTAKEN NOT TO
DISPOSE
OF ANY SHARES OF CO FOR PERIOD AT LEAST 6-MNTHS
Further company coverage: 1952.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Everest Medicines
See all newsBrief: Everest Medicines Says NMPA Approves Cardamyst (Etripamil) NDA For PSVT In Adults In China
Brief: Everest Medicines Enters Commercialization Collaboration With Hainan Herui Pharmaceutical
Brief: Everest Medicines Says CBC Group Purchases 712,000 Everest Medicines Shares For Hk$19.2 Million From 16 To 17 June
Australia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region